Senti Biosciences Holdings, Inc. SNTI
0.16 USD -0.01 (-7.36%)
Nov 5, 2026, 10:35 AM EST
0.1611 Day range 0.173
0.152 52-week range 2.88
- YTD
- -84.27%
- 1 year
- -91.57%
Analyst view
Price target (mean) 12.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -3.13 | -3.13 – -3.13 | 0.00 | 0.0% | 2.80M | 0.0% | 1 |
| Current year | -14.54 | -14.54 – -14.54 | 0.00 | 0.0% | 2.80M | 0.0% | 1 |
| Next year | -1.88 | -1.88 – -1.88 | -14.54 | +87.1% | 5.00M | +78.6% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 4, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Dec 2, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Aug 15, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| May 11, 2023 | Chardan Capital | Maintained | Buy | Buy |
| Mar 24, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Mar 23, 2023 | Chardan Capital | Maintained | — | Buy |
| Jan 30, 2023 | Chardan Capital | Maintained | — | Buy |
| Jan 27, 2023 | Morgan Stanley | Maintained | — | Equal-Weight |
| Dec 16, 2022 | JP Morgan | Initiated | — | Neutral |
| Oct 7, 2022 | Morgan Stanley | Initiated | — | Equal-Weight |
| Sep 29, 2022 | B of A Securities | Initiated | — | Buy |
| Sep 23, 2022 | Chardan Capital | Initiated | — | Buy |